治疗动脉疾病的最佳方法是什么?
Ahmed Abdelkarim1, Mohammed Hamouda1, Mahmoud B Malas1
1Department of Surgery, Division of Vascular and Endovascular Surgery, UC San Diego, San Diego, CA, USA; Center for Learning and Excellence in Vascular & Endovascular Research (CLEVER), UC San Diego, San Diego, CA, USA; Altman Center for Clinical and Translational Research, 9452 Medical Center Drive - LL2W 502A, La Jolla, CA 92037, USA.
Advances in surgery
|August 1, 2024
概括
穿动脉再血管 (TCAR) 为需要穿动脉再血管的高风险患者提供了一个更安全的替代方案,其结果与穿动脉内膜切除术 (CEA) 相似,并且比穿动脉支架 (TFCAS) 有更好的结果.
科学领域:
- 血管外科 血管外科
- 干预心脏病学 干预心脏病学
- 神经学 神经学
背景情况:
- 动脉疾病带来了相当大的中风风险.
- 手术和内血管技术的目的是恢复血液流动.
- 选择最佳的复血管化策略对于患者的治疗结果至关重要.
研究的目的:
- 综合审查和比较心动脉内关节切除术 (CEA),关节外关节动脉支架 (TFCAS) 和心动脉外关节动脉再血管 (TCAR).
- 评估每个技术的安全性和有效性,特别是在高风险患者群体中.
- 为了告知临床决策对于动脉再血管化.
主要方法:
- 对CEA,TFCAS和TCAR现有的文献进行系统审查.
- 对手术结果的比较分析,包括中风率,死亡率和神经保护.
- 评估影响技术选择的患者特定因素.
主要成果:
- Carotid Endarterectomy (CEA) 仍然是一个黄金标准,特别是在老年人和高危人群中.
- 穿越关节动脉支架 (TFCAS) 不那么侵入性,但与更高的周围手术中风风险有关.
- 穿动脉复血管化 (TCAR) 结合了最小侵入性的优势和神经保护,在高风险患者中显示出与CEA相当的疗效和TFCAS优异的结果.
结论:
- 对于接受动脉再血管化的高风险患者来说,TCAR是一个有希望的,更安全的选择.
- 患者的并发症和解剖学的考虑在选择最合适的再血管化策略方面至关重要.
- 进一步的研究可能会完善每个技术的最佳患者选择标准.
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
01:26Angina IV: Management
493
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
01:30Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
958
Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
958
01:26Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
01:27Peripheral Artery Disease III: Interprofessional Care
655
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655